ClinicalTrials.Veeva

Menu

Observational Study on Patients With Chronic Hepatitis B

N

Nanfang Hospital, Southern Medical University

Status

Unknown

Conditions

Chronic Hepatitis B

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The study was conducted to evaluate the effect of anti-viral treatment on long-term outcome on patients with chronic hepatitis B.

Enrollment

10,000 estimated patients

Sex

All

Ages

30+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female, aged over 30 (inclusive) years of old
  • Patients has a history of diagnosis of chronic hepatitis B (ie. HBsAg positive for more than 6 months)
  • For patients with HBsAg positive, patients should be undergoing anti-viral treatment
  • For patients with HBsAg negative, a documented evidence of previous anti-viral treatment should be provided.
  • Life expectancy is more than 1 year
  • Good treatment compliance.

Exclusion criteria

  • Patients has a history of diagnosis of hepatocellular carcinoma
  • Patients with Child Pugh C
  • Coinfected with HCV, HDV and HIV
  • Suffering from other serious disease
  • Taking part in other clinical trial

Trial contacts and locations

14

Loading...

Central trial contact

Jian Sun, MD; Jinlin Hou, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems